Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D01CXD
|
||||
Former ID |
DNC008730
|
||||
Drug Name |
9-(Aminomethyl)-9,10-dihydroanthracene
|
||||
Synonyms |
C-(9,10-Dihydro-anthracen-9-yl)-methylamine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [530331] | ||
Structure |
Download2D MOL |
||||
Formula |
C15H15N
|
||||
Canonical SMILES |
C1C2=CC=CC=C2C(C3=CC=CC=C31)CN
|
||||
InChI |
1S/C15H15N/c16-10-15-13-7-3-1-5-11(13)9-12-6-2-4-8-14(12)15/h1-8,15H,9-10,16H2
|
||||
InChIKey |
GEICAQNIOJFRQN-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Histamine H1 receptor | Target Info | Inhibitor | [530331] | |
5-hydroxytryptamine 2A receptor | Target Info | Inhibitor | [525993] | ||
WikiPathways | Monoamine GPCRs | ||||
GPCRs, Class A Rhodopsin-like | |||||
IL-4 Signaling Pathway | |||||
Gastrin-CREB signalling pathway via PKC and MAPK | |||||
GPCR ligand binding | |||||
GPCR downstream signalingWP733:Serotonin Receptor 2 and STAT3 Signaling | |||||
Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | |||||
SIDS Susceptibility Pathways | |||||
GPCR downstream signaling | |||||
GPCRs, Other | |||||
References | |||||
Ref 525993 | Bioorg Med Chem Lett. 2001 Feb 26;11(4):563-6.Exploring the relationship between binding modes of 9-(aminomethyl)-9,10-dihydroanthracene and cyproheptadine analogues at the 5-HT2A serotonin receptor. | ||||
Ref 530331 | Bioorg Med Chem. 2009 Sep 15;17(18):6496-504. Epub 2009 Aug 13.Synthesis, structure-affinity relationships, and modeling of AMDA analogs at 5-HT2A and H1 receptors: structural factors contributing to selectivity. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.